Almost £50m from pharmacy manufacturers' levy to be used for expansion of NHS clinical trials Funding from the Voluntary Branded Medicines Pricing, Access and Growth (VPAG) scheme is to be used to expand NHS clinical trials. Issued on 4 March 2026, a press release from the National Institute…

The #NIHR said it will use £47.8m from #VPAG to fund equipment “that will increase the ability of the NHS to deliver high-quality commercial research”

#NHS #clinicalresearch #researchfunding

buff.ly/qKMYzdT

MPs push for more details on VPAG and NICE threshold changes The House of Commons Science, Innovation and Technology Committee has called on the government to provide more clarity on the UK–US life sciences deal, which promised 0% tariffs on UK pharmaceutical…

The House of Commons Science, Innovation and Technology Committee has called on the government to provide more clarity on the UK–US life sciences deal

#ukgovernment #VPAG #NICE #lifesciences

Time to emphasise the economics in health economics Victoria Jordan, ABPI Value and Access Policy Director, discusses the Health Economics of the UK-US Economic Prosperity Deal and the commitment to increase NICE's baseline threshold use, the first cha...

#ABPI #NICE #UKUSEconomicProsperityDeal #innovativemedicines #populationhealth #pharmaceuticalindustry #VPAG #StatutorySchemerebates #priceofmedicines #NHSindustrypartnerships #GVA #RandD #UKResearchandInnovation #clinicaltrials #UKmedicineexports #brandedmedicines #NICEthreshold
zurl.co/D8SUt

Following its deal with the US, the British government has cut the payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access.

healthcaretoday.com/article/gove...

#Healthcare #BrandedMedicines #VPAG #Government #UK #US

UK pharma policy at a turning point: NICE threshold reform, VPAG, and global trade signals The ICER threshold increase is expected to allow an additional three to five medicines or indications each year to be recommended for NHS use.

#pharma #NICEthresholdreform #NICE #VPAG #ICERthreshold #VPAGnegotiations #MostFavouredNation #NICEappraisals #NHSadoption #HTAs #PatientAccessSchemes #PASdiscounts #NICEseveritymodifier #ABPI #VPAGagreement #PASstrategies #MarketAccesssolutions #HEORevidence #HTAapprovals
zurl.co/O9uRv

Rebate rate for new medicines falls by almost a third for 2026 The 2026 payment rate for new medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5%.

Rebate rate for new medicines falls by almost a third for 2026

buff.ly/RqMG6Ze

#VPAG #medicines #medicinepricing #pharmacy #UKpharmacy

Our #QuoteoftheWeek is from #RichardTorbett, chief exec of the #ABPI, on the decrease in the payment rate for newer medicines

#VPAG #pharmacynews #drugpricing
buff.ly/gtq2PbY

Medicines rebate rate to fall by more than one-third in 2026 The payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) scheme will fall to 14.5% in 2026, down from 22.5% in 2025. The Department of…

The payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing, Access and Growth scheme will fall to 14.5% in 2026, down from 22.5% in 2025

#ukpharmacy #VPAG

VPAG payment rate for newer medicines will be 14.5% in 2026 The government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5 per cent, down from a record 22.5 pe...

#ABPI #pharma #VPAG #VPAG1 #LifeSciences #Medicinessales #Pharmasales #StatutoryScheme #VoluntaryScheme #VPAGpaymentrate #VoluntarySchemeforBrandedMedicinesPricingandAccess #NHS #UKlifesciencecompetitiveness #NHSadoption #costeffectivemedicines #UKlifesciencesinvestment
zurl.co/5G14Z

NIHR Annual Report 2024/25: Three must-read ways we’re accelerating clinical trial delivery The National Institute for Health and Care Research (NIHR) brings together specialist facilities, research delivery teams and leading experts to create a go-to destination for the life sciences indust...

#NIHR #lifesciences #clinicaltrials #clinicaltrialdelivery #10YearHealthPlan #England #UKVaccineInnovationPathway #VIP #VaccineInnovationPathway #UKVIP #clinicaltrialdeliveryaccelerator #UKClinicalTrialPartnerships #TransformingUKClinicalResearchDelivery #CRDCs #VPAG #NCVR
zurl.co/zHNfI

Landmark deal between the UK and US will expand medicine access for thousands The UK has become the only country in the world to agree a 0% tariff on all pharmaceutical exports to the US for at least three years.

Landmark deal between the UK and US will expand medicine access for thousands

buff.ly/Wk4VQtC

#US #pharmaceuticals #LifeSciences #VPAG #pharmacy #UKpharmacy

UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI Industry hopes the new trade agreement will allow more innovative medicines to reach a greater number of NHS patients and will be a positive step in supporting the UK life sciences industry.

#ABPI #UKUStradedeal #lifesciences #PharmaIndustry #innovativemedicines #UKlifesciencesindustry #lifesciencesinvestment #lifesciencesresearch #pharmaceuticalexports #VPAG #VPAGscheme #NICEthreshold #patientaccess #healthoutcomes #lifescienceinvestment #NHSaccesstomedicines
zurl.co/vi7Md

Landmark deal between the UK and US will expand medicine access for thousands The UK has become the only country in the world to agree a 0% tariff on all pharmaceutical exports to the US for at least three years.

Landmark deal between the UK and US will expand medicine access for thousands

buff.ly/VZd3J3M

#US #pharmaceuticals #LifeSciences #VPAG #pharmacy #UKpharmacy

Third extension to VPAG granted The deadline for companies to give notice on their intention to leave the voluntary scheme for branded medicines pricing, access, and growth is now 16 December.

The deadline for companies to give notice on their intention to leave the voluntary scheme for branded medicines pricing, access, and growth is now 16 December.

healthcaretoday.com/article/thir...

#healthcare #publichealth #VPAG #brandedmedicines

Companies granted third extension to VPAG 2026 decision deadline – now set for 16 December The ABPI and the government have agreed to a further extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, acce...

#ABPI #pharma #pharmaceuticals #PharmaceuticalCompanies #VPAG2026 #UKgovernment #voluntaryschemeforbrandedmedicinespricingaccessandgrowth #VPAGscheme #lifesciencessector #StatutorySchemeforbrandedmedicines #brandedpharmaceuticals #VPAG #VPAG1 #VoluntaryScheme #VoluntarySchemeNews
zurl.co/lJJaE

and non commercial clinical trials activity is needed #OShaughnessy #VPAG

Much more can and should be done. We are working towards a better and fairer Wales. I think theres a fair chance @plaidcymru.bsky.social will take this forward next year, but whoever it is I hope that their focus will always

Companies granted further extension to VPAG 2026 decision deadline The ABPI and the government have agreed to a further two-week extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pric...

#ABPI #pharmaceuticalindustry #pharmaindustry #UKpharmaindustry #VPAG2026 #UKgovernment #2024VPAG #voluntaryschemeforbrandedmedicinespricingaccessandgrowth #VPAG #VPAGscheme #lifesciencessector #StatutorySchemeforbrandedmedicines #StatutoryScheme #VPAG #VoluntaryScheme
zurl.co/P95JM

New VPAG deadline extension announced by ABPI The UK government has extended the deadline for organisations to submit notice to leave the scheme by two additional weeks.

To stay or to go? #VPAG edition.

The ABPI has announced a two week extension for organisations to submit notice on whether they want to be part of scheme in 2026.

Read our write up exploring the issue: www.emjreviews.com/emj-gold/new...

Government considers raising NICE cost-effectiveness threshold to appease pharmaceutical industry After a dispute between the UK government and the pharmaceutical industry over NHS drug pricing, Sir Keir Starmer is prepared to negotiate.

Government considers raising NICE cost-effectiveness threshold to appease pharmaceutical industry

buff.ly/DYKk5Ic

#VPAG #NICE #pharmaceuticals #pharmacy #UKpharmacy #NHS #ABPI

Government considers raising NICE cost-effectiveness threshold to appease pharmaceutical industry After a dispute between the UK government and the pharmaceutical industry over NHS drug pricing, Sir Keir Starmer is prepared to negotiate.

Government considers raising NICE cost-effectiveness threshold to appease pharmaceutical industry

buff.ly/DYKk5Ic

#VPAG #NICE #pharmaceuticals #pharmacy #UKpharmacy #NHS #ABPI

Moderna opens UK facility as drug pricing spat rumbles on The UK government has celebrated the opening of Moderna's £150m vaccines facility, but storm clouds continue to gather on the issue of drug pricing

#vaccines #Moderna #ModernaInnovationandTechnologyCentre #MITC #mRNAvaccines #mRNA #MSD #AstraZeneca #EliLilly #NHSmedicinesspending #BristolMyersSquibb #VPAG #lifesciencespowerhouse #COVID19 #flu #mRNAtechnologies #cancer #rarediseases #lifesciences
pharmaphorum.com/news/moderna...

AbbVie joins BMS in taking a hard line on UK drug pricing AbbVie has said it may not launch its ovarian cancer therapy Elahere in the UK if a viable NHS price cannot be agreed with NICE.

#AbbVie #BMS #BristolMyersSquibb #UKdrugpricing #pharmagroup #newmedicines #UK #USA #ovariancancertherapy #Elahere #NHSpatients #reimbursementauthority #NICE #schizophrenia #Cobenfy #pharmacompanies #Trump #medicineprices #MHRA #VPAG #rebates #NHS #MSD #EliLilly #AstraZeneca
zurl.co/d8CQZ

Big pharma firms have paused nearly £2bn in UK investments this year Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

#lifesciences #biotech #Pharmaceuticals #AstraZeneca #Trump #MSD #EliLilly #drugpricing #ABPI #BristolMyersSquibb #NHS #VPAG #Sanofi #Novartis #BioNTech #Moderna #Haleon #Indivior #VeronaPharma #AdaptimmuneTherapeutics #WorldMeds #GSK #RentschlerBiopharma #Recipharm
zurl.co/3FQOT

UK set on resolving standoff with big pharma, science minister says Patrick Vallance says relations must improve and NHS has to reverse decline in drugs investment

#pharmaindustry #Pharmaceuticalsindustry #PatrickVallance #NHS #bigpharma #druginvestment #medicinesspending #lifescienceindustry #healthcarespend #newmedicines #equitableaccess #MHRA #NICE #pricingmodels #cuttingedgetreatments #medicinepricingmechanism #VPAG #ABPI
zurl.co/6ghNy

PeopleWith Health | PeopleWith, Putting People First. | PeopleWith With the latest announcement of the challenging VPAG rebates within the UK affecting Life Science profitability in the UK market, the need to have robust patient outcomes data & insights to enhance st...

UK Pharma is facing one of its toughest moments yet with the VPAG rebate pressures.

On 2 Oct 25, PeopleWith launch an innovation that unlocks insights from 7m UK patients, helping teams make faster, smarter, compliant decisions.
lnkd.in/p/ecvYc8BH
#VPAG #Pharma #PeopleWith #UK

Pharma says UK is 'tumbling down' rankings for investment The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects, says a report from the ABPI pharma group.

#pharmaceuticals #Pharmainvestment #RandD #clinicaltrials #capitalprojects #innovativenewmedicines #pharmaindustry #ABPI #VPAG #brandedmedicines #pharmaceuticalcompanies #healthcarespending #biotech #pharmaceuticalinnovation #lifesciencespowerhouse #AI #cellandgenetherapies
zurl.co/aDLED

NHS medicine pricing policy row escalates after talks break down An impasse has developed between the UK government and the pharmaceutical industry over NHS medicine pricing.

NHS medicine pricing policy row escalates after talks break down

buff.ly/xvCtyFN

#VPAG #NHS #ABPI #DHSC #pharmacy #drugs #medicines

NHS medicine pricing policy row escalates after talks break down An impasse has developed between the UK government and the pharmaceutical industry over NHS medicine pricing.

NHS medicine pricing policy row escalates after talks break down

buff.ly/xvCtyFN

#VPAG #NHS #ABPI #DHSC #pharmacy #drugs #medicines

20-21 PHARMA - Same difference -

#biosimilarsindustry #biosimilars #NHS #longtermhealthconditions #healthandsocialcarespending #Chronicdiseases #BritishBiosimilarsAssociation #NHSreinvestment #NHSmedicinescosts #pharmaceuticalspending #biosimilarsadoption #VPAG #biosimilarmanufacturers #NHStenders #NHSresources
zurl.co/soiB5

Tough talk from Streeting – but he still needs a deal with big pharma Health secretary calls industry ‘shortsighted’ but there is danger in giving UK better terms than much of rich Europe

#pharma #pharmaceuticals #pharmaindustry #WesStreeting #UK #pharmaceuticalcompanies #priceofprescriptionmedicines #prescriptionmedicines #Pharmaceuicalpricing #ABPI #UKlifesciences #Trump #NHS #voluntarypricingschemes #VPAG #NHSbudget #NICE #lifesciencesstrategy #TrumpTariffs
zurl.co/ARfrH